Relay Therapeutics CFO Executes Stock Sale Following RSU Vesting
Thomas Catinazzo, the Chief Financial Officer of Relay Therapeutics, Inc. (NASDAQ: RLAY), has completed a sale of company common stock. The transaction, valued at $14,375, occurred on April 28, 2026. The shares were sold at a price point of $14.79 per share, which represents a premium compared to the current trading level of $12.96.The sale involve…